Literature DB >> 22970439

Ventricular systolic reserve in asymptomatic children previously treated with low doses of anthracyclines: a longitudinal, prospective exercise echocardiography study.

Fabio V Guimaraes-Filho1, Doralice M Tan, Joao C F Braga, Alexandre Rodrigues, Paulo H Waib, Beatriz B Matsubara.   

Abstract

BACKGROUND: The time course of mild cardiotoxicity induced by anthracycline remains unknown. The aim of this study was to evaluate the long-term evolution of decreased myocardial reserve in children previously treated with a cumulative dose of anthracycline up to 100 mg/m(2). PATIENTS AND METHODS: Twenty-seven asymptomatic cancer survival patients (25 with lymphoblastic leukemia), in continuous remission and off treatment for >12 months with no alterations in conventional echocardiograms were evaluated by exercise echocardiography at 37 ± 15.4 months (T1) and 101 ± 24 months (T2) after finishing treatment (ADRIA group). This group was compared with 25 healthy individuals (control group) similar to the ADRIA group with respect to age and body surface area (BSA). All individuals underwent treadmill exercise testing according to Bruce protocol. Echocardiograms were performed before and immediately after exercise.
RESULTS: The groups were similar regarding cardiac structure and left ventricular (LV) systolic function at rest at T1 and T2. The growth of LV posterior wall thickness related to BSA was lower in the ADRIA group at T2. Post exercise, smaller LV ejection indexes and attenuated changes in the afterload in ADRIA group were observed at T1 and T2.
CONCLUSION: The decreased systolic reserve induced by a low dose of anthracycline in asymptomatic children and adolescents remains unaffected over a 5-year period, suggesting that positive outcomes in chronic cardiotoxicity would be expected in patients with mild impairment after anthracycline treatment.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22970439     DOI: 10.1002/pbc.24000

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  5 in total

1.  Cardiopulmonary Exercise Testing Characterizes Silent Cardiovascular Abnormalities in Asymptomatic Pediatric Cancer Survivors.

Authors:  Takeshi Tsuda; Daphney Kernizan; Austin Glass; Gina D'Aloisio; Jobayer Hossain; Joanne Quillen
Journal:  Pediatr Cardiol       Date:  2022-09-08       Impact factor: 1.838

Review 2.  Current and emerging modalities for detection of cardiotoxicity in cardio-oncology.

Authors:  Michel G Khouri; Michael R Klein; Eric J Velazquez; Lee W Jones
Journal:  Future Cardiol       Date:  2015-08-03

Review 3.  Aerobic exercise in anthracycline-induced cardiotoxicity: a systematic review of current evidence and future directions.

Authors:  Joseph J Chen; Pei-Tzu Wu; Holly R Middlekauff; Kim-Lien Nguyen
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-12-06       Impact factor: 5.125

Review 4.  The utility of cardiac stress testing for detection of cardiovascular disease in breast cancer survivors: a systematic review.

Authors:  Amy A Kirkham; Sean A Virani; Kristin L Campbell
Journal:  Int J Womens Health       Date:  2015-01-23

Review 5.  The Utility of Cardiac Reserve for the Early Detection of Cancer Treatment-Related Cardiac Dysfunction: A Comprehensive Overview.

Authors:  Stephen Foulkes; Guido Claessen; Erin J Howden; Robin M Daly; Steve F Fraser; Andre La Gerche
Journal:  Front Cardiovasc Med       Date:  2020-03-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.